Icatibant Acetate is sold under the trade name “Firazyr”, and is classified under the drug class of “Bradykinin B2 receptor antagonist”. It is used to treat acute attacks of hereditary angioedema, ACE inhibitor-associated angioedema, liver disease, burns, and burn infection. Subcutaneous (SC) injection of Icatibant Acetate at a dose of 30 mg is recommended for use in the abdomen. There may be a need for additional doses to be given at least every 6 hours if the response is insufficient or the symptoms recur. In 24 hours, no more than three doses may be administered. Known drug interactions are with Ramipril, Enalaprilat, Captopril, Fosinopril, Lisinopril and Benazipril. Side effects associated with this pharmaceutical medicine include allergic reactions to the site of injection, abnormal liver function tests, headache, dizziness, rash, fever, and many more. It is not yet been approved by the FDA as safe during pregnancy because there are no related studies available. However, animal studies show premature birth, abortion, and delayed parturition. For breastfeeding candidates, it is recommended that it should be done after 12 hours of drug administration. It is administered through a subcutaneous route in form of subcutaneous liquid. It was approved by the FDA on August 25, 2011, under the trade name “Firazyr” and currently has orphan drug status in the United States.

Bradykinin causes symptoms of hereditary angioedema, so this drug blocks action of bradykinin and relieves the condition.

For a bulk supply of 3 ml of Icatibant Acetate 10 mg/ml, it costs around 2,950 dollars. This price may fluctuate from seller to seller.

Pipelinepharma is designed to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Icatibant Acetate manufacturers and suppliers can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this pharmaceutical medication. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Icatibant Acetate . Moreover, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Icatibant Acetate is already registered in. These manufacturers and suppliers that are registered on our website may have certain special terms for deals.

Finding a reliable business partner is one of the most difficult tasks, and Pipelinepharma's website can assist you in finding a reliable manufacturer and supplier of Icatibant Acetate. As a B2B licensing retail market for pharmaceutical medicines, Pipelinepharma connects sellers with customers to help them grow their businesses. An intuitive and unified search engine lets you filter product names by country, category, therapeutic area, and more. You can also lookup product names by regulatory filings, approval status, and more.

Pipelinepharma provides a safe and secure online platform for both drug sellers and buyers to conduct business. The site verifies the seller’s information, as soon as they register on the site. The site performs all quality control procedures. It's safe to use the site's services because they're reliable and authentic.